Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New IOLs may eliminate need for eyeglasses and contact lenses

18.08.2004


For most people, the need to wear eyeglasses to read is an inevitable part of aging. The eye’s natural lens hardens and loses its ability to change shape, making it more difficult to focus, especially when reading up close.



With age also comes the development of cataracts or clouding of the eye’s natural lens. Intraocular lenses (IOLs) traditionally have been used to replace the eye’s natural lens after its removal during cataract surgery. However, with the traditional IOLs, most patients still needed to wear glasses for reading and using the computer. This, however, may be changing.

The FDA recently approved the Crystalens, the first of a new generation of IOLs that, in many cases, can allow people to see without eyeglasses or contact lenses. American Academy of Ophthalmology spokesperson Neil F. Martin, M.D., F.A.C.S., of Chevy Chase, Md., "Unlike older fixed-focus IOLs that do not move, the Crystalens is able to move and can focus like a younger eye’s natural lens." The Crystalens use hinges, which are attached to the eye’s muscles. This allows the lens to move, or accommodate, so you can focus on objects near, far and all distances in-between seamlessly.


What about Crystalens for people who haven’t yet developed cataracts? Although FDA-approved for cataract patients, the Crystalens is a physician-discretionary alternative to LASIK for boomer-aged patients contemplating vision correction. Patients with astigmatism may have relaxing incisions at the time of Crystalens implantation or they may have LASIK afterwards. Patients considering this form of vision correction should consult an eye surgeon who is an expert in Crystalens implantation and LASIK to determine the best option.

Dr. Martin, who is clinical assistant professor of ophthalmology at the Georgetown University School of Medicine-Washington National Eye Center combined Departments of Ophthalmology said, "The ideal candidates for Crystalens IOLs are about 50 or older. The candidate should have healthy eyes, other than perhaps having cataracts. Patients who have previously had cataract surgery or significant eye disease, such as glaucoma, macular degeneration or diabetic retinal disease are not good candidates for this procedure."

"The procedure costs about $5,000 per eye. For people with cataracts, insurance usually covers half the cost. Financing and cafeteria-plan accounts may make the Crystalens procedure more affordable," Dr. Martin said. Unfortunately, Medicare currently does not cover Crystalens IOLs for patients with cataracts or allow for cataract patients to pay for upgrades themselves.

There are other accommodating IOLs that are currently awaiting FDA approval. Dr. Martin does expect the FDA to formally approve the IOLs for people who don’t have cataracts, but wish to have their refractive errors corrected.

Media Relations | EurekAlert!
Further information:
http://www.aao.org

More articles from Health and Medicine:

nachricht Finding new clues to brain cancer treatment
21.02.2020 | Case Western Reserve University

nachricht UIC researchers find unique organ-specific signature profiles for blood vessel cells
18.02.2020 | University of Illinois at Chicago

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A step towards controlling spin-dependent petahertz electronics by material defects

The operational speed of semiconductors in various electronic and optoelectronic devices is limited to several gigahertz (a billion oscillations per second). This constrains the upper limit of the operational speed of computing. Now researchers from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg, Germany, and the Indian Institute of Technology in Bombay have explained how these processes can be sped up through the use of light waves and defected solid materials.

Light waves perform several hundred trillion oscillations per second. Hence, it is natural to envision employing light oscillations to drive the electronic...

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

Im Focus: Skyrmions like it hot: Spin structures are controllable even at high temperatures

Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices

The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...

Im Focus: Making the internet more energy efficient through systemic optimization

Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.

Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.

Im Focus: New synthesis methods enhance 3D chemical space for drug discovery

After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.

"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

Active droplets

21.02.2020 | Medical Engineering

Finding new clues to brain cancer treatment

21.02.2020 | Health and Medicine

Beyond the brim, Sombrero Galaxy's halo suggests turbulent past

21.02.2020 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>